Vaccine could be ready in October

PFIZER INC. $36 is a buy. The prescription drugmaker (New York symbol PFE; Income Portfolio, Manufacturing & Industry sector; Shares outstanding: 5.6 billion; Market cap: $201.6 billion; Dividend yield: 4.2%; Dividend Sustainability Rating: Highest; last raised its quarterly dividend in March 2020. Investors now receive $0.38 a share,… Read More

Pfizer remains our top drug stock

We now see several promising opportunities emerging in the pharmaceutical drug industry, and we will probably recommend more drug stocks in the next few years. For now, we feel Pfizer offers our readers the best combination of growth and income in a pharma stock. Since… Read More